Knight Therapeutics Inc. logo

Knight Therapeutics Inc.

TSX:GUD.TO

Overview | Financials
Company Name Knight Therapeutics Inc.
Symbol GUD.TO
Currency CAD
Price 5.15
Market Cap 520,026,400
Dividend Yield 0%
52-week-range 5.07 - 6.23
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Samira Sakhia BCom, CA, CPA, MBA
Website https://www.gud-knight.com

An error occurred while fetching data.

About Knight Therapeutics Inc.

Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada, Latin America, and internationally. It offers Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib

Related Stocks

Extendicare Inc. logo

Extendicare Inc.

EXE.TO

10.18 CAD

Aurora Cannabis Inc. logo

Aurora Cannabis Inc.

ACB.TO

0.59 CAD

WELL Health Technologies Corp. logo

WELL Health Technologies Corp.

WELL.TO

5.18 CAD

OrganiGram Holdings Inc. logo

OrganiGram Holdings Inc.

OGI.TO

1.41 CAD

HLS Therapeutics Inc. logo

HLS Therapeutics Inc.

HLS.TO

3.37 CAD

Neighbourly Pharmacy Inc. logo

Neighbourly Pharmacy Inc.

NBLY.TO

18.6 CAD

Theratechnologies Inc. logo

Theratechnologies Inc.

TH.TO

1.71 CAD

Viemed Healthcare, Inc. logo

Viemed Healthcare, Inc.

VMD.TO

8.765 CAD

Sienna Senior Living Inc. logo

Sienna Senior Living Inc.

SIA.TO

16.8 CAD

Financials

Numbers are in millions USD

Numbers are in millions USD